Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-L Deng

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Environmental Toxicology and Pharmacology|January 2, 2016
The Fusarium toxin zearalenone and deoxynivalenol affect murine splenic antioxidant functions, interferon levels, and T-cell subsetsZ H Ren, H D Deng, Y C Wang, et al.
Polish Journal of Veterinary Sciences|July 7, 2020
17 beta-estradiol affects proliferation and apoptosis of canine bone marrow mesenchymal stem cells in vitroZ-H Zhou, C-W Gu, J Li, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|September 12, 2022
[A comparison of CAS risk model and CHA<sub>2</sub>DS<sub>2</sub>-VASc risk model in guiding anticoagulation treatment in Chinese patients with non-valvular atrial fibrillation]J L Deng, L He, C Jiang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Environmental Toxicology and Pharmacology|January 2, 2016
The Fusarium toxin zearalenone and deoxynivalenol affect murine splenic antioxidant functions, interferon levels, and T-cell subsetsZ H Ren, H D Deng, Y C Wang, et al.
Polish Journal of Veterinary Sciences|July 7, 2020
17 beta-estradiol affects proliferation and apoptosis of canine bone marrow mesenchymal stem cells in vitroZ-H Zhou, C-W Gu, J Li, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|September 12, 2022
[A comparison of CAS risk model and CHA<sub>2</sub>DS<sub>2</sub>-VASc risk model in guiding anticoagulation treatment in Chinese patients with non-valvular atrial fibrillation]J L Deng, L He, C Jiang, et al.
Pageof 2